Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy (SALT)

This study has been completed.
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by (Responsible Party):
Fundacion SEIMC-GESIDA
ClinicalTrials.gov Identifier:
NCT01307488
First received: March 1, 2011
Last updated: May 8, 2015
Last verified: May 2015